CORCEPT THERAPEUTICS INC (CORT) earnings date
Feb 23, 2027, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 45% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 34 days, typically, give or take 11 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Tue, Nov 3, 2026 | after close | 34 | 8-K |
| Q2 FY2026 | Wed, Jul 29, 2026 | after close | 29 | 8-K |
| Q1 FY2026 | Thu, Apr 30, 2026 | after close | 30 | 8-K |
| Q4 FY2025 | Tue, Feb 24, 2026 | after close | 55 | 8-K |
| Q3 FY2025 | Tue, Nov 4, 2025 | after close | 35 | 8-K |
| Q2 FY2025 | Thu, Jul 31, 2025 | after close | 31 | 8-K |
| Q1 FY2025 | Mon, May 5, 2025 | after close | 35 | 8-K |
| Q4 FY2024 | Wed, Feb 26, 2025 | after close | 57 | 8-K |
What they guided beta
| Q3 FY2026 | "Reiterated 2026 revenue guidance of $1.1 – $1.2 billion" exhibit Read from the sentence: revenue $1.1 billion to $1.2 billion, FY2026 |
| Q3 FY2026 | "We expect continued growth in both businesses and have reiterated our 2026 revenue guidance of $1.1 – $1.2 billion.”" exhibit |
| Q3 FY2026 | "Marketing Authorization Application (MAA) – European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended in September 2026 that the European Commission should approve our MAA for relacorilant plus nab-paclitaxel to treat patients with platinum-resistant ovarian cancer – Approval expected by the end of this year Relacorilant in Combination with Androgen Deprivation Therapy" exhibit |
| Q2 FY2026 | "Increase in 2026 revenue guidance to $1.1 – $1.2 billion" exhibit Read from the sentence: revenue $1.1 billion to $1.2 billion, FY2026 |
| Q2 FY2026 | "We anticipate continued strength across our businesses and have increased our 2026 revenue guidance to $1.1 – $1.2 billion,” said Joseph K." exhibit |
| Q2 FY2026 | "We expect a decision on our NDA by December 17, 2026." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/CORT
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/CORT
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/CORT/"><img src="https://veritasdata.dev/embed/CORT.svg" alt="CORT earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/CORT/)
Script
<script async src="https://veritasdata.dev/embed/CORT.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/CORT"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.